OHSU Knight Cancer Institute

Search by Disease

Adult Cancers

Adolescent and Young Adult (AYA) (13)

Brain Tumors / Neurologic Cancers (5)

Breast Cancer (13)

Endocrine Cancers (2)

Gastrointestinal Cancers (30)

Gastrointestinal stromal tumor (GIST) (4)

Gynecologic Cancers (3)

Head and Neck Cancers (4)

Hematologic Cancers (88)

Lifestyle / Behavioral (2)

Lung Cancers (9)

Melanoma (5)

Non-Melanoma Skin Cancers (3)

Sarcoma (8)

Urologic / Genitourinary Cancers (9)

Prostate (15)

Preventive Care (2)

Phase I Clinical Trials (19)

Supportive Care (4)

Other (4)

Childhood Cancers

* Contact our Pediatric Office: phocras2@ohsu.edu

Brain and Nervous System

Cancer of brain and central nervous system (4)

Childhood Cancers

* Contact our Pediatric Office: phocras2@ohsu.edu

Search by Drug

Find a Clinical Trial By Drug

[18F] Fluoroestradiol (FES) (1)
177-Lu-PSMA-617 (1)
5-FU (1)
ABBV-399 (1)
Abemaciclib (1)
ABL001 (3)
Abraxane (6)
ABT-165 (1)
acalabrutinib (1)
acetaminophen (2)
ACP-196 (2)
ACP-319 (2)
ADI-PEG 20 (1)
ADRIAMYCIN (4)
ADRUCIL (1)
AFINITOR (1)
AG-120 (ivosidenib) (1)
AG-221 (2)
Alectinib (1)
ALIMTA (5)
Alkeran (4)
ALRN-6924 (1)
AM0010/Pegilodecakin (1)
AMETHOPTERIN (1)
AP1903 (dimerizer drug) (1)
apalutamide (1)
ARIMIDEX (1)
AROMASIN (1)
ASTX727 (Cedazuridine and Decitabine Fixed-Dose Combination) (1)
Atezolizumab (4)
avapritinib (BLU-285) (1)
AVASTIN (3)
Avelumab (1)
AZD4547 (2)
BA3011 (1)
BA3021 (1)
BENADRYL (2)
Bevacizumab (RO4876646) (1)
BGB-290 (1)
BGB-3111 (1)
BI 836826 (1)
BI836858 (1)
BICNU (2)
Bicnu, Giladel (1)
BioLine (1)
BL-8040 (1)
BLU-285 (2)
BLU-667 (1)
BMS 986016 (relatlimab) (1)
BMS 986205 (IDO1 inhibitor) (1)
BMS-813160 (CCR2/5 Dual Antagonist) (1)
BMS936558 (1)
BMS-986016 (2)
BMS-986158 (1)
BOSULIF (1)
BPX-501 (1)
BPX-501 T Cells (iCasp9 modified T cells and AP1903) (1)
BPX-701 (1)
BUSULFEX (1)
Cabiralizumab (FPA008) (1)
CAMPTOSAR (3)
capmatinib (1)
Carboplatin (2)
CASODEX (2)
CELEBREX (1)
CELLCEPT (1)
Cellectra (combination product) (1)
CERUBIDINE (5)
Cobimetinib (2)
COMETRIQ (3)
COREG (1)
CORT125281 (1)
CPX-351 (2)
crenolanib (1)
CV301 (1)
CX-01 (1)
CYTOSAR (10)
Cytosar or Tarabine PFS (2)
CYTOXAN (8)
DACOGEN (4)
DCC-2618 (1)
DCC-3014 (1)
DCDS4501A (2)
DCDT2980S (2)
Decadron (20)
Depocyt (3)
Dexamethasone (2)
DPX-SURVIVAC (1)
Durvalumab (3)
EC-18 (1)
EFUDEX (4)
Ellence (3)
ELOXATIN (11)
Emactuzumab (RO5509554) (1)
Enasidenib (AG-221) (1)

Entospletinib (1)
Entospletinib (ENTO) (3)
Entrectinib (2)
Epacadostat (2)
ERBITUX (1)
Etophos, Toposar (2)
Etopophos (2)
EULEXIN (1)
FARYDAK (1)
FELDENE (1)
FEMARA (1)
FERAHEME (3)
Ferumoxytol (2)
FIRMAGON (2)
Floxuridine (1)
FLUDARA (3)
fluorouracil (6)
FT-2102 (1)
Fusilev (2)
G100 (glucopyranosyl lipid A stable emulsion, GLA-SE (1)
Gadolinium (1)
Gamida (1)
GAZYVA (8)
GDC-0032 (2)
GEMZAR (11)
Gengraf (1)
GENMAB (7)
Gilotrif (1)
Gilteritinib (2)
Gilteritinib (ASP2215) (1)
GLEEVEC (2)
Herceptin (1)
HYCAMTIN (1)
HYDREA (1)
HYLENEX RECOMBINANT (1)
IBRANCE (1)
ICLUSIG (4)
Iclusig® (1)
Idamycin (3)
IFEX (2)
IMBRUVICA (7)
IMGN779 (1)
INCB 52793-101 (1)
INCB050465 (1)
INCB054828 (1)
INO-5401 (1)
INO-9012 (1)
Inotuzumab Ozogamicin (1)
Investigator's Brochure - v10 Tracked Changes - PEGPH20 (1)
Isatuximab (1)
Itacitinib (2)
ixazomib (1)
Ixazomib (MLN 9708) (1)
Jakafi (6)
Janssen (1)
Jevtana (2)
KEYTRUDA (12)
KYPROLIS (2)
LAG525 (1)
LENALIDOMIDE (1)
LENVIMA (2)
LEUCOVORIN (9)
Leukeran (1)
LOVENOX (1)
LOXO-195 (1)
LOXO-292 (1)
LUPRON (1)
Lupron, Eligard (1)
MBG453 (1)
MEDI4736 (2)
MEDROL (1)
MEKINIST (1)
Melphalan (2)
Merck (1)
Merck Sharp & Dohme Corp (1)
MESNEX (1)
midostaurin (1)
MLN9708 (2)
Montelukast (1)
MPDL3280A (2)
MYLOTARG (1)
n/a (1)
Napabucasin (1)
NAVELBINE (1)
Navitoclax (1)
NEORAL (1)
NEULASTA (1)
NEUPOGEN (4)
NEXAVAR (7)
NILANDRON (1)
NKTR-214 (1)
NOLVADEX (1)
Novantrone (2)
Olaparib (4)
ONCASPAR (2)

ONCOVIN (4)
ONO/GS-4059 (1)
OPDIVO (19)
Palbociclib (2)
Paraplatin (8)
Patidegib (1)
Pazopanib (1)
PDR001 (2)
PEGASYS (1)
PERJETA (2)
Pevodnedistat (1)
Pevonedistat (1)
PLATINOL (8)
Polatuzumab vedotin (1)
Pomalyst (1)
prednisone (4)
PROGRAF (2)
ProHance (2)
ProTmune (1)
PURINETHOL (1)
Quizartinib (AC220) (2)
RAPAMUNE (1)
REGN2810 (1)
Revlimid (9)
rHuPH20 (1)
ribociclib (1)
Rilotumumab (2)
Rimducid (AP1903/Dimerizer drug) (1)
Rimiducid (1)
RITUXAN (12)
Rituxan Hycela (1)
RO6874281 (1)
Rovalpituzumab Tesirine (Rova-T) (1)
RUBRACA (1)
rucaparib (1)
Samalizumab (1)
savolitinib (1)
SD-101 (1)
Selicrelumab (RO7009789) (1)
selinexor (1)
SGN-LIV1A (2)
sodium thiosulfate (2)
SOMATULINE AUTOGEL (1)
Sprycel (4)
SPRYCEL® (1)
stivarga (3)
Sutent (7)
TABLOID (1)
TAK-079 (1)
TAK-700 (Orteronel) (1)
tamibarotene (1)
TARCEVA (2)
Tarceva, OSI-774 (1)
Tasigna (3)
Tasigna™ (1)
Tasinga (1)
TAXOL (4)
TAXOTERE (4)
tazemetostat (1)
TEMODAR (1)
TG-1101 (1)
TICE BCG (1)
tisotumab vedotin (1)
TREANDA (6)
TRELSTAR (1)
tremelimumab (1)
TREXALL (1)
TSR-042 (1)
TTI-621 (1)
Tucatinib (1)
T-VEC (1)
Umbralisib (1)
VANTAS (1)
Various drugs will be assessed in the sub-studies (1)
VELCADE (10)
Venclexta (3)
Venetoclax (3)
VEPESID (1)
VESANOID (1)
VIDAZA (12)
Voruciclib (1)
Vyxeos (1)
Wyeth Pharmaceuticals, Inc (1)
XALKORI (1)
Xeloda (3)
XTANDI (6)
YERVOY (10)
Zarxio (1)
ZELBORAF (1)
ZEN003694 (1)
ZOFRAN (2)
ZOLADEX (2)
zolbetuximab (1)
Zolinza (3)
ZYDELIG (3)
ZYTIGA (5)

Flowcharts

Clinical Trial Flowcharts

Bone Marrow Transplant

Breast

Breast

Endocrine

Gastrointestinal

Gastrointestinal Stromal Tumor (GIST)

Gastrointestinal Stromal Tumor (GIST)

Genitourinary

Gynecologic

Gynecology

Head and Neck

Head + Neck

Hematologic

Kidney

Renal

Lung

Melanoma and Non-Melanoma Skin Cancers

Neurology

Neurological Surgery

Oncology Supportive Care

General Oncology Supportive Care

Phase 1

Phase 1 Program

Prostate

Radiation Oncology

Radiation Oncology

Sarcoma

Childhood Cancers	Supportive Care Preventive Care

We make every effort to publish all clinical trials but some cannot be publicly advertised.
Please contact us for more information.

For more information:
Email: trials@ohsu.edu
Call: 503-494-1080